WASHINGTON — The Pharmaceutical Care Management Association, which represents drug middlemen in Washington, filed a lawsuit Tuesday to block implementation of one of President Trump’s signature drug pricing policies.
The policy at issue would prevent drug makers and middlemen from negotiating rebates on prescription drugs. The policy has been controversial even within the Trump administration: The administration first proposed the idea in January 2019 but abandoned it in July of that year, only to pick up again last November.
About the Author Reprints
